Copyright Reports & Markets. All rights reserved.

Global Traumatic Brain Injury Therapeutics Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Traumatic Brain Injury Therapeutics Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Traumatic Brain Injury Therapeutics Market Size Growth Rate by Product
      • 1.4.2 Acetylcholinesterase Inhibitors
      • 1.4.3 Erythropoietin
      • 1.4.4 Growth Hormone
      • 1.4.5 Stem Cells
      • 1.4.6 Others
    • 1.5 Market by End User
      • 1.5.1 Global Traumatic Brain Injury Therapeutics Market Size Growth Rate by End User
      • 1.5.2 Focal TBI
      • 1.5.3 Open TBI
      • 1.5.4 Closed TBI
      • 1.5.5 Diffuse TBI
      • 1.5.6 Primary TBI
      • 1.5.7 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Traumatic Brain Injury Therapeutics Market Size
      • 2.1.1 Global Traumatic Brain Injury Therapeutics Revenue 2014-2025
      • 2.1.2 Global Traumatic Brain Injury Therapeutics Sales 2014-2025
    • 2.2 Traumatic Brain Injury Therapeutics Growth Rate by Regions
      • 2.2.1 Global Traumatic Brain Injury Therapeutics Sales by Regions
      • 2.2.2 Global Traumatic Brain Injury Therapeutics Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Traumatic Brain Injury Therapeutics Sales by Manufacturers
      • 3.1.1 Traumatic Brain Injury Therapeutics Sales by Manufacturers
      • 3.1.2 Traumatic Brain Injury Therapeutics Sales Market Share by Manufacturers
      • 3.1.3 Global Traumatic Brain Injury Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2 Traumatic Brain Injury Therapeutics Revenue by Manufacturers
      • 3.2.1 Traumatic Brain Injury Therapeutics Revenue by Manufacturers (2014-2019)
      • 3.2.2 Traumatic Brain Injury Therapeutics Revenue Share by Manufacturers (2014-2019)
    • 3.3 Traumatic Brain Injury Therapeutics Price by Manufacturers
    • 3.4 Traumatic Brain Injury Therapeutics Manufacturing Base Distribution, Product Types
      • 3.4.1 Traumatic Brain Injury Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Traumatic Brain Injury Therapeutics Product Type
      • 3.4.3 Date of International Manufacturers Enter into Traumatic Brain Injury Therapeutics Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Traumatic Brain Injury Therapeutics Sales by Product
    • 4.2 Global Traumatic Brain Injury Therapeutics Revenue by Product
    • 4.3 Traumatic Brain Injury Therapeutics Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Traumatic Brain Injury Therapeutics Breakdown Data by End User

    6 North America

    • 6.1 North America Traumatic Brain Injury Therapeutics by Countries
      • 6.1.1 North America Traumatic Brain Injury Therapeutics Sales by Countries
      • 6.1.2 North America Traumatic Brain Injury Therapeutics Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Traumatic Brain Injury Therapeutics by Product
    • 6.3 North America Traumatic Brain Injury Therapeutics by End User

    7 Europe

    • 7.1 Europe Traumatic Brain Injury Therapeutics by Countries
      • 7.1.1 Europe Traumatic Brain Injury Therapeutics Sales by Countries
      • 7.1.2 Europe Traumatic Brain Injury Therapeutics Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Traumatic Brain Injury Therapeutics by Product
    • 7.3 Europe Traumatic Brain Injury Therapeutics by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Traumatic Brain Injury Therapeutics by Countries
      • 8.1.1 Asia Pacific Traumatic Brain Injury Therapeutics Sales by Countries
      • 8.1.2 Asia Pacific Traumatic Brain Injury Therapeutics Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Traumatic Brain Injury Therapeutics by Product
    • 8.3 Asia Pacific Traumatic Brain Injury Therapeutics by End User

    9 Central & South America

    • 9.1 Central & South America Traumatic Brain Injury Therapeutics by Countries
      • 9.1.1 Central & South America Traumatic Brain Injury Therapeutics Sales by Countries
      • 9.1.2 Central & South America Traumatic Brain Injury Therapeutics Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Traumatic Brain Injury Therapeutics by Product
    • 9.3 Central & South America Traumatic Brain Injury Therapeutics by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Traumatic Brain Injury Therapeutics by Countries
      • 10.1.1 Middle East and Africa Traumatic Brain Injury Therapeutics Sales by Countries
      • 10.1.2 Middle East and Africa Traumatic Brain Injury Therapeutics Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Traumatic Brain Injury Therapeutics by Product
    • 10.3 Middle East and Africa Traumatic Brain Injury Therapeutics by End User

    11 Company Profiles

    • 11.1 SFC Fluidics LLC
      • 11.1.1 SFC Fluidics LLC Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 SFC Fluidics LLC Traumatic Brain Injury Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 SFC Fluidics LLC Traumatic Brain Injury Therapeutics Products Offered
      • 11.1.5 SFC Fluidics LLC Recent Development
    • 11.2 Banayan Biomarkers Inc.
      • 11.2.1 Banayan Biomarkers Inc. Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Banayan Biomarkers Inc. Traumatic Brain Injury Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Banayan Biomarkers Inc. Traumatic Brain Injury Therapeutics Products Offered
      • 11.2.5 Banayan Biomarkers Inc. Recent Development
    • 11.3 BHR Pharma LLC
      • 11.3.1 BHR Pharma LLC Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 BHR Pharma LLC Traumatic Brain Injury Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 BHR Pharma LLC Traumatic Brain Injury Therapeutics Products Offered
      • 11.3.5 BHR Pharma LLC Recent Development
    • 11.4 Cerora Inc.
      • 11.4.1 Cerora Inc. Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Cerora Inc. Traumatic Brain Injury Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Cerora Inc. Traumatic Brain Injury Therapeutics Products Offered
      • 11.4.5 Cerora Inc. Recent Development
    • 11.5 ElMindA Ltd.
      • 11.5.1 ElMindA Ltd. Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 ElMindA Ltd. Traumatic Brain Injury Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 ElMindA Ltd. Traumatic Brain Injury Therapeutics Products Offered
      • 11.5.5 ElMindA Ltd. Recent Development
    • 11.6 Grace Laboratories LLC
      • 11.6.1 Grace Laboratories LLC Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Grace Laboratories LLC Traumatic Brain Injury Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Grace Laboratories LLC Traumatic Brain Injury Therapeutics Products Offered
      • 11.6.5 Grace Laboratories LLC Recent Development
    • 11.7 KeyNeurotek Pharmaceuticals AG
      • 11.7.1 KeyNeurotek Pharmaceuticals AG Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 KeyNeurotek Pharmaceuticals AG Traumatic Brain Injury Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 KeyNeurotek Pharmaceuticals AG Traumatic Brain Injury Therapeutics Products Offered
      • 11.7.5 KeyNeurotek Pharmaceuticals AG Recent Development
    • 11.8 Luoxis Diagnostics
      • 11.8.1 Luoxis Diagnostics Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Luoxis Diagnostics Traumatic Brain Injury Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Luoxis Diagnostics Traumatic Brain Injury Therapeutics Products Offered
      • 11.8.5 Luoxis Diagnostics Recent Development
    • 11.9 Neuro Assessment Systems
      • 11.9.1 Neuro Assessment Systems Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Neuro Assessment Systems Traumatic Brain Injury Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Neuro Assessment Systems Traumatic Brain Injury Therapeutics Products Offered
      • 11.9.5 Neuro Assessment Systems Recent Development
    • 11.10 Neurovive Pharmaceuticals AB
      • 11.10.1 Neurovive Pharmaceuticals AB Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Neurovive Pharmaceuticals AB Traumatic Brain Injury Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Neurovive Pharmaceuticals AB Traumatic Brain Injury Therapeutics Products Offered
      • 11.10.5 Neurovive Pharmaceuticals AB Recent Development
    • 11.11 Oxygen Biotherapeutics Inc.
    • 11.12 Phlogistix LLC
    • 11.13 Neurohealing Pharmaceuticals
    • 11.14 Neuren Pharmaceuticals Ltd.
    • 11.15 Remedy Pharmaceuticals Inc.
    • 11.16 Biodirection Inc.
    • 11.17 Brainscope Company Inc.
    • 11.18 TEVA Pharmaceutical Industries Ltd.
    • 11.19 Vasopharm

    12 Future Forecast

    • 12.1 Traumatic Brain Injury Therapeutics Market Forecast by Regions
      • 12.1.1 Global Traumatic Brain Injury Therapeutics Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Traumatic Brain Injury Therapeutics Revenue Forecast by Regions 2019-2025
    • 12.2 Traumatic Brain Injury Therapeutics Market Forecast by Product
      • 12.2.1 Global Traumatic Brain Injury Therapeutics Sales Forecast by Product 2019-2025
      • 12.2.2 Global Traumatic Brain Injury Therapeutics Revenue Forecast by Product 2019-2025
    • 12.3 Traumatic Brain Injury Therapeutics Market Forecast by End User
    • 12.4 North America Traumatic Brain Injury Therapeutics Forecast
    • 12.5 Europe Traumatic Brain Injury Therapeutics Forecast
    • 12.6 Asia Pacific Traumatic Brain Injury Therapeutics Forecast
    • 12.7 Central & South America Traumatic Brain Injury Therapeutics Forecast
    • 12.8 Middle East and Africa Traumatic Brain Injury Therapeutics Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Traumatic Brain Injury Therapeutics Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Traumatic Brain Injury Therapeutics market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Traumatic Brain Injury Therapeutics market based on company, product type, end user and key regions.

      This report studies the global market size of Traumatic Brain Injury Therapeutics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Traumatic Brain Injury Therapeutics in these regions.
      This research report categorizes the global Traumatic Brain Injury Therapeutics market by top players/brands, region, type and end user. This report also studies the global Traumatic Brain Injury Therapeutics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      SFC Fluidics LLC
      Banayan Biomarkers Inc.
      BHR Pharma LLC
      Cerora Inc.
      ElMindA Ltd.
      Grace Laboratories LLC
      KeyNeurotek Pharmaceuticals AG
      Luoxis Diagnostics
      Neuro Assessment Systems
      Neurovive Pharmaceuticals AB
      Oxygen Biotherapeutics Inc.
      Phlogistix LLC
      Neurohealing Pharmaceuticals
      Neuren Pharmaceuticals Ltd.
      Remedy Pharmaceuticals Inc.
      Biodirection Inc.
      Brainscope Company Inc.
      TEVA Pharmaceutical Industries Ltd.
      Vasopharm

      Market size by Product
      Acetylcholinesterase Inhibitors
      Erythropoietin
      Growth Hormone
      Stem Cells
      Others
      Market size by End User
      Focal TBI
      Open TBI
      Closed TBI
      Diffuse TBI
      Primary TBI
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Traumatic Brain Injury Therapeutics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Traumatic Brain Injury Therapeutics market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Traumatic Brain Injury Therapeutics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Traumatic Brain Injury Therapeutics submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Traumatic Brain Injury Therapeutics are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Traumatic Brain Injury Therapeutics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now